ClinicalTrials.gov
public full text
Public Domain
Cardiac Effects of Spiolto®/Respimat® in Patients With Congestive Heart Failure and COPD
The aim of this study is to evaluate the pulmonary and cardiac effects of the LABA / LAMA combination Tiotropium / Olodaterol therapy in patients suffering from both congestive heart failure and chronic obstructive pulmonary disease.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Changes in Physical Functioning in Patients With COPD During Therapy With a Combination Inhalation Therapy#1137730
- Effect of Physiotherapy in Hospitalized COPD Patients#969387
- Sit-to-stand and Peripheral Muscle Strength in COPD#855491
- Acute Effect of Whole-body Electrical Stimulation in COPD Patients#917264
- Evaluation of Utility Quadriceps Magnetic Stimulation in COPD (Chronic Obstructive Pulmonary Disease) Patients After Hospital Exacerbation#878853
Record · ID 848145
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive